Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Head and Neck Neoplasms 1Head and Neck Carcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Adenocarcinoma of Lung 1

Interventions

Standard of Care 5Practice Guidelines as Topic 5Magnetic Resonance Spectroscopy 2pembrolizumab 1X-Rays 1Surgery, Computer-Assisted 1Solutions 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Neurofeedback 1Monitoring, Physiologic 1Interviews as Topic 1Indocyanine Green 1Docetaxel 1DEAE-Dextran 1Counseling 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Head and Neck Carcinoma × Solutions × Head & Neck × Clear all
NCT03745690 2022-03-17

Near-Infrared Image Guided Surgical Resection With Indocyanine Green in Treating Patients With Head and Neck Cancer

Jonsson Comprehensive Cancer Center

Phase 1/2 Withdrawn
Head & Neck

Head and Neck Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡